Citius Oncology, Inc. 8-K Filing Report – February 14, 2025 Insights

The provided XML segment contains key financial and corporate information regarding Citius Oncology, Inc. Here are the most important insights extracted from the text:

1. Company Identification:

• Name: Citius Oncology, Inc.
• CIK Number: 0001851484
• Stock Ticker: CTOR
• Exchange: NASDAQ
• State of Incorporation: Delaware (DE)

2. Reporting Details:

• Filing Type: 8-K
• Filing Date: February 14, 2025

3. Period Information:

• As of Date: February 14, 2025
• Reporting Period: The reporting period is a single day, February 14, 2025.

4. Contact Information:

• Address: 11 Commerce Drive, 1st Floor, Cranford, NJ 07016
• Phone Number: 908-967-6677

5. Financial Units:

• Reporting is done in USD (US Dollars).
• There is a mention of shares, indicating that the report may include stock-related information.

6. Miscellaneous Information:

• The filing indicates that it is not marked as confidential and does not include any flags that would suggest issues with the submission.

Summary:

This document is an 8-K filing by Citius Oncology, Inc. on February 14, 2025, reporting on matters pertinent to that date. The company is a publicly traded entity on NASDAQ under the ticker CTOR, and it operates out of Cranford, NJ. The report likely contains updates or disclosures required by the SEC, though specific details about the content were not included in the provided excerpt.